These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 14391601)

  • 1. [Problem of blood coagulation in obstetrics and gynecology. I. Fibrinogenemia in complicated pregnancy].
    MICHAŁKIEWICZ W
    Ginekol Pol; 1955; 26(2):193-203. PubMed ID: 14391601
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibrinogen B: its diagnostic and prognostic value in obstetrics gynecology].
    VASCIAVEO L
    Minerva Ginecol; 1953 Mar; 5(5):161-4. PubMed ID: 13071787
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE USE OF INJECTABLE FIBRINOGEN IN SURGERY AND OBSTETRICS].
    SOULIER JP
    Sangre (Barc); 1963; 42():305-11. PubMed ID: 14112679
    [No Abstract]   [Full Text] [Related]  

  • 4. [Variations in fibrinogenemia, prothrombin time and liquoid coagulation time during treatment with anticoagulants].
    FRANCESCON M; BUTTO M
    Acta Med Patav; 1952; 13(6):265-88. PubMed ID: 13039951
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinogen derived inhibitors of blood coagulation.
    KOWALSKI E
    Thromb Diath Haemorrh; 1960; 4(Suppl)():211-23. PubMed ID: 13753710
    [No Abstract]   [Full Text] [Related]  

  • 6. [The content of fibrinogen in the blood during menstruation and pregnancy].
    POMASKINA AN
    Akush Ginekol (Mosk); 1960; 36():14-6. PubMed ID: 13736938
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies of the interrelationships between fibrinogen and polysaccharides in various pathological states. I. Contribution to the study of the influence of dextran on fibrinogen].
    STOICHITA M; TEICAN-GHEORGHIU M
    Stud Cercet Med Interna; 1962; 3():741-7. PubMed ID: 13984284
    [No Abstract]   [Full Text] [Related]  

  • 8. [Quantitative studies on fibrinogen reduction in cadaveric blood].
    SCHLEYER F
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1950; 211(3):292-302. PubMed ID: 14790710
    [No Abstract]   [Full Text] [Related]  

  • 9. The reducing properties of fibrinogen; the role of SH groups in the clotting of fibrinogen.
    BAGDY D; GUBA F
    Hung Acta Physiol; 1948; 1(6):197-210. PubMed ID: 18894927
    [No Abstract]   [Full Text] [Related]  

  • 10. The separation of AHF from fibrinogen.
    van CREVELD ; VEDER HA; PASCHA CN; KROEZE WF
    Thromb Diath Haemorrh; 1959 Sep; 3():572-7. PubMed ID: 13812831
    [No Abstract]   [Full Text] [Related]  

  • 11. [The fibrinogenemia of the newborn].
    SALAZAR DE SOUSA C; CRESPO FERREIRA J; FERREIRA GOMES A; ESTRELA A
    Arch Fr Pediatr; 1953; 10(5):474-9. PubMed ID: 13081188
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on afibrinogenemia. I. Afibrinogenemia in a patient with septic abortion, acute yellow atrophy of the liver and bacteremia due to E. coli.
    CONLEY CL; RATNOFF OD; HARTMANN RC
    Bull Johns Hopkins Hosp; 1951 May; 88(5):402-13. PubMed ID: 14830933
    [No Abstract]   [Full Text] [Related]  

  • 13. The interaction of protamine with human fibrinogen and the significance of this interaction for the coagulation of fibrinogen.
    GODAL HC
    Scand J Clin Lab Invest; 1960; 12(4):433-45. PubMed ID: 13706168
    [No Abstract]   [Full Text] [Related]  

  • 14. [Role of fibrinogen B in intravascular coagulation and in determination of preoperative state].
    GUITARTE MS; WALTON AG
    Rev Asoc Med Argent; 1950 Oct 15-30; 64(687-688):451-3. PubMed ID: 14808729
    [No Abstract]   [Full Text] [Related]  

  • 15. [Separation of fibrinogen and of the antihemophilic factor A].
    SOULIER JP; GOBBI F; LARRIEU MJ
    Rev Hematol; 1957; 12(4):481-96. PubMed ID: 13518868
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical significance of fibrinogen-heparin-balance].
    GOTTINGER E
    Med Klin; 1951 Mar; 46(12):361-3. PubMed ID: 14842531
    [No Abstract]   [Full Text] [Related]  

  • 17. [Coagulation of fibrinogen by thrombin; action of some antagonists in the absence and in the presence of ionized calcium].
    BURSTEIN M
    C R Seances Soc Biol Fil; 1950 Jun; 144(11-12):750-2. PubMed ID: 14783855
    [No Abstract]   [Full Text] [Related]  

  • 18. [Coagulation of fibrinogen by thrombin; action of some antagonists after warming of plasma].
    BURSTEIN M
    C R Seances Soc Biol Fil; 1950 Oct; 144(19-20):1338-9. PubMed ID: 14812704
    [No Abstract]   [Full Text] [Related]  

  • 19. [Significance of the lungs for some coagulation factors. I. The lungs and fibrinogen].
    MICHEL D; SCHULZ FH; HARTLEB O
    Klin Wochenschr; 1957 Apr; 35(8):401-4. PubMed ID: 13450230
    [No Abstract]   [Full Text] [Related]  

  • 20. [Time of fibrinogen-fibrin conversion in normal blood clotting].
    BRAUNSTEINER H; REIMER EE
    Wien Z Inn Med; 1950 Oct; 31(10):375-7. PubMed ID: 14798856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.